| HLX07 |
Advanced Soild Tumours
|
Phase Ib/II
|
The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined with Chemotherapy in Advanced Solid Tumors
|
| HLX07 |
Advanced Soild Tumours
|
Phase I
|
An Open-label, Phase I Study to Determine the Maximum Tolerated Dose of HLX07,in Patients with Advanced Solid Cancers
|
| HLX04 |
Healthy Male Subjects
|
Phase I
|
Pharmacokinetic, Safety and Immunogenicity Similarity
Study of HLX04 Versus Avastin®
|
| HLX04 |
metastatic Colorectal Cancer (mCRC)
|
Phase III
|
A Phase III Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab in the First-line Treatment of mCRC
|
| HLX03 |
Healthy Male Subjects
|
Phase I
|
A Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of HLX03 and Humira®
|
